Search results
Hace 15 horas · Tokugawa Ieyasu. Tokugawa Ieyasu [a] [b] (born Matsudaira Takechiyo; [c] January 31, 1543 – June 1, 1616) was the founder and first shōgun of the Tokugawa shogunate of Japan, which ruled from 1603 until the Meiji Restoration in 1868. He was one of the three "Great Unifiers" of Japan, along with his former lord Oda Nobunaga and fellow Oda ...
9 de may. de 2024 · Takeda estimates it will incur about $900 million in restructuring costs during the coming fiscal year, which runs from April to March. The company aims to to improve its core operating profit margin by 1% to 2.5% each year from 2025 on, targeting an eventual range in the low-to-mid 30%.
Hace 4 días · Updated: 29 May 2024. SOLD. Antique Japanese Sword Katana Signed by Shinano Kami Nobuyoshi. NBTHK Hozon Certificate. ¥ 850,000. DELIVERY TIME: Approx. 1-1.5 months. *We ship from Tokyo, Japan. There might be delay in shipment depending on countries. SHIPPING TO: USA, UK, Canada, Mexico, Germany, Hong Kong, France, Australia.
9 de may. de 2024 · La farmacéutica japonesa Takeda se anotó un beneficio neto de 144.100 millones de yenes (863 millones de euros) en el conjunto de su año fiscal, finalizado en marzo, lo que equivale a un descenso...
9 de may. de 2024 · TOKYO, May 9 (Reuters) - Japan's Takeda Pharmaceutical (4502.T) announced a restructuring on Thursday after annual profit slid by more than half following the loss of patent protection of major...
13 de may. de 2024 · May 13, 2024. Share. Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class active immunotherapy designed to delay or slow Alzheimer’s disease progression.
9 de may. de 2024 · Share. OSAKA, Japan, May 9, 2024 – Takeda ( TSE:4502/NYSE:TAK ) today announced financial results for fiscal year 2023 (period ended March 31, 2024). Takeda delivered its Management Guidance for Core Operating Profit and exceeded its Management Guidance for Revenue and Core EPS performance at CER.
